BSE filing, NSE: BIOFILCHEM. Summary written from the filing by ALFA Finder's alert engine.
Biofil Chemicals & Pharmaceuticals Ltd: key numbers
- Share price
- ₹28.68
- Market cap
- ₹46.67 Cr
- Revenue (annual)
- ₹28.40 Cr
- Net profit (annual)
- ₹2.79 Cr
- P/E (TTM)
- 96.4×Sector 45.9×
- Promoter holding
- 46.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Biofil Chemicals & Pharmaceuticals Ltd
All →Biofil Chemicals & Pharmaceuticals Other Announcement
The company submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30th September 2026, confirming compliance with depository norms.
Biofil Chemicals & Pharmaceuticals Annual General Meeting
Biofil Chemicals and Pharmaceuticals Limited held its 41st Annual General Meeting on 23rd September 2026. Members transacted routine business, including adoption of financial statements and director re-appointments.
Biofil Chemicals & Pharmaceuticals Other Announcement
Biofil Chemicals is notifying shareholders with unregistered email addresses about how to access the Annual Report and AGM Notice, per Regulation 36(1)(b) compliance requirements.
Biofil Chemicals & Pharmaceuticals Annual Report
Biofil Chemicals and Pharmaceuticals Limited has submitted its Integrated Annual Report for FY 2025-26. The 41st Annual General Meeting is scheduled for September 23, 2026.
Biofil Chemicals & Pharmaceuticals Annual General Meeting
Biofil Chemicals and Pharmaceuticals Limited will hold its 41st Annual General Meeting on September 23, 2026. The meeting will be conducted via video conferencing.
Biofil Chemicals & Pharmaceuticals Management Change
Biofil Chemicals announced the continuation of Mr. Ashok Kumar Ramawat as a Non-Executive Independent Director, subject to shareholder approval at the upcoming AGM.
Other management change announcements
All →Tata Motors Management Change
B S R & Co. LLP resigned as statutory auditor, citing Iveco group alignment. Deloitte Haskins & Sells LLP was appointed to fill the vacancy.
Fortis Healthcare Management Change
Fortis Healthcare's Chief Growth & Innovation Officer, Dr. Ritu Garg, resigned effective close of business on October 31, 2026. The resignation is a senior management personnel change with no monetary impact stated.
Menon Pistons Management Change
Menon Pistons appointed Dr. D.T. Shirke as Non-Executive Independent Director for 36 months from 31 October 2026. Neha Marathe's independent directorship concluded on completion of tenure.
Tribhovandas Bhimji Zaveri Management Change
Tribhovandas Bhimji Zaveri appointed two Managing Directors and a Dy. CEO, and three executive directors resigned. The board reorganisation follows a change in control.
S A Tech Software India Management Change
S A Tech Software India disclosed that Company Secretary and Compliance Officer Arnika Choudhary resigned, effective close of business November 20, 2026. The company is hiring a replacement and will inform the exchanges once filled.
Signoria Creation Management Change
Signoria Creation's board noted the resignation of independent director Harsha Tinker and reconstituted its key committees effective 31 October 2026. No monetary value is involved.